1. Proteomic analysis of dorsal root ganglia in a mouse model of paclitaxel-induced neuropathic pain.
- Author
-
Hanna, Rania, Graur, Alexandru, Sinclair, Patricia, Mckiver, Bryan D., Bos, Paula D., Damaj, M. Imad, and Kabbani, Nadine
- Subjects
- *
DORSAL root ganglia , *CELL division , *SENSORY neurons , *PERIPHERAL neuropathy , *NEURALGIA , *ELECTROSPRAY ionization mass spectrometry , *PURINERGIC receptors - Abstract
Paclitaxel is a chemotherapy drug widely used for the treatment of various cancers based on its ability to potently stabilize cellular microtubules and block division in cancer cells. Paclitaxel-based treatment, however, accumulates in peripheral system sensory neurons and leads to a high incidence rate (over 50%) of chemotherapy induced peripheral neuropathy in patients. Using an established preclinical model of paclitaxel-induced peripheral neuropathy (PIPN), we examined proteomic changes in dorsal root ganglia (DRG) of adult male mice that were treated with paclitaxel (8 mg/kg, at 4 injections every other day) relative to vehicle-treated mice. High throughput proteomics based on liquid chromatography electrospray ionization mass spectrometry identified 165 significantly altered proteins in lumbar DRG. Gene ontology enrichment and bioinformatic analysis revealed an effect of paclitaxel on pathways for mitochondrial regulation, axonal function, and inflammatory purinergic signaling as well as microtubule activity. These findings provide insight into molecular mechanisms that can contribute to PIPN in patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF